Browse Category

Stock Market News 11 December 2025

US Stock Market Today, December 11, 2025: Dow Climbs While Oracle-Led AI Sell-Off Hits Nasdaq After Fed Rate Cut

US Stock Market Today, December 11, 2025: Dow Climbs While Oracle-Led AI Sell-Off Hits Nasdaq After Fed Rate Cut

New York, December 11, 2025 — Wall Street is split the day after the Federal Reserve’s latest interest-rate cut. The Dow Jones Industrial Average is pushing higher, while the S&P 500 and tech‑heavy Nasdaq are under pressure as investors punish AI-linked stocks, led by a steep drop in Oracle. By late morning in New York, Reuters and AP data showed the Dow up roughly 0.6–0.9%, but the S&P 500 down around 0.2–0.5% and the Nasdaq off close to 1%, as heavy selling in mega‑cap tech offset strength in banks, industrials and small caps. Reuters+1 This choppy session comes less than 24 hours after the S&P 500 closed
EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

European equities shook off an early wobble on Thursday, with most major EU indices closing solidly in the green as investors rotated into economically sensitive sectors and financials – even as technology stocks struggled under renewed AI‑bubble fears. The EU stock market today (11 December 2025) was shaped by three big forces: last night’s U.S. Federal Reserve rate cut, a cautious but supportive Swiss National Bank (SNB) decision, and a wave of stock‑specific news from Schneider Electric to Naturgy and Delivery Hero. Reuters+3Financial Times+3Reuters+3 How EU stock markets performed today By the closing bell on 11 December 2025: Intraday, the tone
Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

Canada Stock Market Today: TSX Near Record High as Mining Stocks Climb, Tech and Energy Lag – December 11, 2025

Canada’s stock market continued its record‑setting run on Thursday, with the S&P/TSX Composite Index trading just above the 31,500 mark as investors weighed surging metal prices, a fresh trade surplus, and this week’s back‑to‑back interest‑rate decisions from the Bank of Canada and the U.S. Federal Reserve. TradingView+1 By late morning in Toronto, the S&P/TSX was up about 0.3% around 31,546, a new intraday high, after briefly opening in the red. TradingView+1 Gains in gold and base‑metal miners offset a sharp pullback in technology shares and another weak session for energy stocks, leaving the Canada stock market today looking more like a sector‑rotation story than a broad rally. TSX
11 December 2025
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group Incorporated (NYSE: UNH) has been at the center of one of 2025’s biggest blue‑chip storylines: a brutal share-price collapse, a messy reset in Medicare Advantage, a Department of Justice (DOJ) probe, credit‑rating downgrades, and now a tentative turn toward recovery. Since November 21, 2025, a fresh wave of news, forecasts, and opinion pieces has reshaped how investors view UNH stock. Below is a structured, Google‑News‑friendly rundown of what’s happened from November 21, 2025 through today (December 11, 2025), what Wall Street expects for 2026, and what risks still hang over the story. UNH Stock Snapshot as of December
11 December 2025
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

NEW YORK – December 11, 2025 – Shares of Immunovant, Inc. (NASDAQ: IMVT) were sharply in focus on Thursday after the clinical‑stage immunology company announced a $550 million common stock financing designed to fund development and a potential commercial launch of its lead FcRn inhibitor, IMVT‑1402, in Graves’ disease.Immunovant, Inc.+1 By late afternoon, Immunovant stock was trading around $25.75, up roughly 9% on the day, with an intraday range between $22.03 and $25.87, giving the company a market value of about $4 billion.Stock Titan That upbeat finish came despite an initial sell‑off; one early report noted shares dropped around 7%
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Inc. (NYSE: ABBV) has quietly turned into one of 2025’s standout large‑cap pharma stories. Shares are up roughly a mid‑20% percentage year‑to‑date, outpacing the broader market, powered by booming sales of Skyrizi and Rinvoq, a fresh dividend hike, and a string of oncology milestones — capped by an HSBC upgrade that just put AbbVie on the firm’s “preferred buys” list for 2026. Barchart.com+224/7 Wall St.+2 At the same time, the stock is still trading below its early‑October high, and investors are weighing Humira’s ongoing decline, softness in aesthetics, and regulatory risk against that growth story. Here’s a detailed look
Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Updated: December 11, 2025 Coeur Mining, Inc. (NYSE: CDE) has turned into one of 2025’s most dramatic comeback stories in precious metals. The U.S.-based gold‑and‑silver producer has delivered record cash flow, launched its largest exploration push in more than a decade, and unveiled a $7 billion all‑stock acquisition of New Gold Inc. that would create a new North American mining heavyweight. Coeur Mining+2Proactiveinvestors NA+2 At the same time, the stock has gone from forgotten mid‑cap to momentum darling. On December 11, 2025, CDE is trading around $16.84 per share, up roughly 5% intraday, with a session range between about $15.89
Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

As of December 11, 2025, Snowflake Inc. (NYSE: SNOW) sits right at the intersection of three powerful storylines: explosive AI demand, nervousness about profit margins, and mounting legal and regulatory risk. Since November 21, 2025, those threads have come together in a way that has materially reshaped the stock’s risk–reward profile. Snowflake shares currently trade around $218 per share, down roughly 7% from their $234.03 close on November 21, and about 22% below the three‑year high of $280.67 set on November 3. Investing.com+1 Even after the post‑earnings sell‑off, the stock remains more than 50% higher year‑to‑date, reflecting how central Snowflake
Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde plc (NASDAQ: LIN) has had a turbulent end to 2025. After setting a fresh 52‑week low in late November, the world’s largest industrial gases company has attracted a wave of new analyst calls, insider buying from its CEO, and multiple debt and credit transactions that reshape its balance sheet and liquidity profile. This article pulls together the most important news, forecasts and analyses on Linde stock from November 21, 2025 through December 11, 2025, and sets them in the context of the company’s latest earnings and 2026 outlook. 1. Linde stock snapshot as of December 11, 2025 As of
11 December 2025
Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku Stock Jumps on Fresh Analyst Upgrades: Is NASDAQ:ROKU Setting Up for a 2026 Breakout?

Roku, Inc. (NASDAQ: ROKU) is back on center stage. On Thursday, December 11, 2025, the streaming platform’s stock is trading around the $109–110 mark, up strongly on the day and hovering near the top of its 52‑week range of roughly $52 to $117.Investing.com+1 A wave of new analyst calls, upbeat earnings trends, and a clearer path to profitable growth are now reshaping how Wall Street looks at Roku stock going into 2026. Roku Stock Today: Price, Momentum and Market Context Across major data providers, Roku’s share price sits in the low $100s, with today’s session pushing it close to the
11 December 2025
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio, Inc. (NASDAQ: BLTE) has turned into one of 2025’s most closely watched biotech stories. On the back of a pivotal Phase 3 win in Stargardt disease and a large equity raise, the small-cap ophthalmology specialist has seen its share price more than double this year and its market value climb into the multi‑billion‑dollar range.BioPharma Dive+1 As of the afternoon of December 11, 2025, Belite Bio stock is trading around $154 per share, up roughly 4–5% on the day and more than 130% year‑to‑date, giving the company a market capitalization of roughly $5–6 billion.Stock Titan+1 The rally has pushed
11 December 2025
Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair Inc. (NYSE: W) is back in the market spotlight. As of Thursday, December 11, 2025, the online home-goods retailer’s stock is trading around $99–100 per share, up roughly 7% on the day from a prior close near $93.³Investing.com That move caps a roller-coaster year in which Wayfair has: Today’s story is a tug‑of‑war: hedge funds are buying, insiders have been selling, and analysts are sharply divided between rich upside and cooling enthusiasm. Below is a breakdown of the key news, forecasts, and analyses dated December 11, 2025, and how they fit into the bigger picture for Wayfair stock. Wayfair
Qualcomm (QCOM) Stock News: AI Chip Breakthroughs, Ventana Deal and 2026 Outlook After November 21 Pivot

Qualcomm (QCOM) Stock News: AI Chip Breakthroughs, Ventana Deal and 2026 Outlook After November 21 Pivot

December 11, 2025 Qualcomm Incorporated (NASDAQ: QCOM) has moved from a choppy, headline‑driven November to a decisively AI‑centric story in early December, helped by new data‑center chips, a strategic acquisition in RISC‑V CPUs and fresh automotive AI announcements ahead of CES 2026. Since closing in the mid‑$160s on November 21, Qualcomm stock has climbed roughly 9% to about $179.55 in Thursday trading, outpacing many large semiconductor peers. Traders Union At the same time, Wall Street forecasts now cluster just above current levels, while technical analysts warn that QCOM looks overbought in the short term even as its long‑term AI and
11 December 2025
Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo & Company’s stock has surged into record territory heading into year‑end 2025, powered by the removal of its Federal Reserve asset cap, a massive new share buyback plan and an aggressive push into artificial intelligence — even as fresh regulatory scrutiny and legal settlements keep risks in focus. This article reviews the key news, forecasts and analyses on Wells Fargo stock from November 21, 2025 through December 11, 2025, and explains what they could mean for investors watching WFC into 2026. WFC performance since 21 November: rally near all‑time highs As of the close on December 10, 2025,
Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork Inc. (NASDAQ: UPWK) has quietly turned into one of the more interesting AI-adjacent small-cap stories on the market. As of December 11, 2025, the online work marketplace is trading around new 52‑week highs near $21–22 per share, after a run of positive news: record Q3 results, long‑term growth targets, strategic AI partnerships, entry into the S&P SmallCap 600, and a new international AI hub in Lisbon. Investing.com Canada+1 At the same time, heavy insider selling, elevated short interest and concerns about AI replacing some freelance work are keeping the bear case alive. That mix of euphoria and anxiety is
Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology, Inc. (NASDAQ: MRVL) has had a dramatic few weeks. Since November 21, 2025, when the stock traded around the high‑$70s, Marvell has reported record earnings, announced a multi‑billion‑dollar AI acquisition, seen analysts race to lift price targets — and then been hit by sharp sell‑offs on fears about its business with Amazon and Microsoft. Investors+3Yahoo Finance+3Marvell Technology, Inc.+3 As of December 11, 2025, MRVL is changing hands near $90–91, up roughly 17% from its November 21 close of $77.45, but below the post‑earnings highs near $100 earlier this month. Yahoo Finance+1 Below is a detailed look at the
Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Published: December 11, 2025 – covers developments from November 21, 2025 onward. This article is for informational purposes only and is not investment advice. Where Coca-Cola Stock Stands Today The Coca‑Cola Company (NYSE: KO) is trading around $69–70 per share intraday on December 11, 2025, down modestly from late‑November highs above $73 but still well above its 52‑week low of about $60.62.Investing.com Over the past 12 months, KO has delivered roughly high‑single- to low‑double‑digit percentage gains, with Zacks/Nasdaq estimating an 11.9% one‑year return, outperforming the soft‑drinks industry but lagging the S&P 500’s ~14.9% rise.Nasdaq+1 At current levels, Coca‑Cola trades on
Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum Holdings Inc. (NASDAQ: LITE) has transformed from a struggling optical-component supplier into one of 2025’s most explosive AI‑infrastructure plays. After a string of blowout quarters and aggressive price‑target hikes, the stock hit an all‑time high of about $300.20 on November 26, 2025, and now trades around $366 per share as of December 11. Investing.com From November 21, 2025 onward, the newsflow around Lumentum has been dominated by three themes: Below is a detailed, SEO‑optimized rundown of the latest news, forecasts and analyses since November 21, 2025, and what they could mean for LITE stock. Lumentum Stock Snapshot (as of
11 December 2025
Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International, Inc. (NYSE: EAT) — the parent of Chili’s Grill & Bar and Maggiano’s Little Italy — is back in the market spotlight. On December 11, 2025, Brinker shares are trading around $146, up roughly 7% intraday, after bouncing between $135.85 and $146.00 so far in today’s session. That puts the stock about 24% below its 52‑week high near $192 and roughly 46% above its 52‑week low around $100, underscoring how volatile the turnaround story has been for investors over the past year. Investing.com+1 Company snapshot: a Chili’s‑powered turnaround Brinker operates more than 1,600 restaurants worldwide under the Chili’s
Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Updated December 11, 2025 — Ticker: NYSE: HD Home Depot, Inc. (HD) is ending 2025 in a tricky spot: the housing market is soft, do‑it‑yourself demand is sluggish, but the company is still investing heavily in its “pro” customer, supply chain, and long‑term growth. Since November 21, 2025, a wave of earnings reports, cautious guidance, and analyst revisions has reshaped the outlook for Home Depot stock. Here’s a detailed look at what’s changed, what Wall Street expects next, and how the risk–reward profile of HD is evolving. Home Depot stock today: still below its highs As of the afternoon of

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop